| 注册
首页|期刊导航|特产研究|川芎嗪治疗冠心病作用及机制研究进展

川芎嗪治疗冠心病作用及机制研究进展

杨松柏 尹健 侯旭晖

特产研究2024,Vol.46Issue(5):165-172,8.
特产研究2024,Vol.46Issue(5):165-172,8.DOI:10.16720/j.cnki.tcyj.2024.172

川芎嗪治疗冠心病作用及机制研究进展

Research Progress on the Effect and Mechanism of Ligustrazine in Treat-ing Coronary Heart Disease

杨松柏 1尹健 1侯旭晖1

作者信息

  • 1. 吉林大学中日联谊医院,血管外科,吉林 长春 130031
  • 折叠

摘要

Abstract

Ligustrazine is extracted from Ligusticum chuanxiong Hort.of Umbelliferae,which is one of the main components of the plant and belongs to a common Chinese medicine.With the in-depth study of ligustrazine in pharmacology,drugs are widely used in clinic,espe-cially in the treatment of cardiovascular diseases.Tetramethylpyrazine is the chemical structure of ligustrazine.The drug works on the basis that four methyl groups are replaced by different functional gene groups,and has the functions of promoting blood circulation,removing blood stasis,protecting vascular endothelium,dilating coronary artery and antiplatelet.In recent years,ligustrazine is often used in the treat-ment of cardiovascular diseases,and has achieved remarkable therapeutic effects.This paper summarized the effect of ligustrazine on cor-onary heart disease,focusing on the mechanism of ligustrazine in treating coronary heart disease,such as anti-platelet activation,inhibition of platelet aggregation,vasodilation,etc.,and provides theoretical reference for the further development of ligustrazine in treating coronary heart disease.

关键词

川芎嗪/冠心病/抗血小板活化

Key words

Ligustrazine/coronary heart disease/antiplatelet activation

分类

医药卫生

引用本文复制引用

杨松柏,尹健,侯旭晖..川芎嗪治疗冠心病作用及机制研究进展[J].特产研究,2024,46(5):165-172,8.

基金项目

吉林大学横向基金课题项目(20210301) (20210301)

特产研究

OACSTPCD

1001-4721

访问量0
|
下载量0
段落导航相关论文